-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $105

Benzinga·02/26/2026 22:15:45
Listen to the news
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $95 to $105.